Search results
Author(s):
Maki Komiyama
,
Hiromichi Wada
,
Hajime Yamakage
,
et al
Added:
3 years ago
Best Poster Award
Topic: 1. Clinical Cardiology
Introduction and Objectives
Vessel wall Inflammation promotes the destabilization of atherosclerotic plaques. The lectin-like oxidized low- density lipoprotein (LDL) receptor-1 (LOX-1) expressed by vascular cells and monocytes. LOX index is calculated by multiplying LOX-1 ligand containing apolipoprotein B level with the soluble LOX-1. A high…
View more
Author(s):
Wolfgang Koenig
Added:
3 years ago
The notion that atherosclerosis carries features of an inflammatory disease has existed for quite some time. As early as 1856, Rudolf Virchow in his Textbook on Pathology mentioned the term “coronaritis”. Almost 150 years later, following the elucidation of major cardiovascular risk factors in the 1950s Framingham Study, Russell Ross entitled his 1999 review on mechanisms of atherosclerosis …
View more
Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit…
Author(s):
Marco Rossato
,
Angelo Di Vincenzo
Added:
3 years ago
Article
Author(s):
Maki Komiyama
,
Koji Hasegawa
Added:
3 years ago
The novel coronavirus disease 2019 (COVID-19) first occurred in December 2019 in Wuhan, Hubei Province, China, and has already evolved into a rapidly expanding pandemic. The WHO has declared COVID-19, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), to be a public health emergency of international concern.1 Until effective therapeutics and vaccines become available…
View more
Author(s):
Sayaka Shimada
,
Maki Komiyama
,
Hiromichi Wada
,
et al
Added:
3 years ago
Topic: 5. Secondary Prevention of Cardiovascular Disease.
Introduction and Objectives
It is reported that 3 months of professional smoking cessation treatment achieves an initial smoking cessation rate of 80%. However, a 1 year cessation rate decreases to approximately 50%. The most common causes of relapse are weight gain, stress, and nicotine withdrawal symptoms. Relapse prevention is…
View more
Inflammation in Arterial Disease
Author(s):
Christos D Liapis
,
Elias A Kaperonis
Added:
3 years ago
Article
Author(s):
Maki Komiyama
,
Koji Hasegawa
Added:
3 years ago
Thank you very much for your interesting and important comments on our review that discussed smoking cessation to limit the coronavirus disease 2019 (COVID-19) pandemic.1,2 As you pointed out, the reported number of hospitalised COVID-19 patients who are current or former smokers is small.3,4 One reason for this small number of smokers is that an unknown history of smoking may be treated as a non…
View more
Author(s):
Natalie Arnold
,
Katharina Lechner
,
Christoph Waldeyer
,
et al
Added:
2 years ago
Author(s):
Koji Hasegawa
,
Maki Komiyama
,
Yuko Takahashi
Added:
3 years ago
Smoking is a strong risk factor for the development of arteriosclerotic cardiovascular disease (CVD). Quitting smoking is a cornerstone of improved cardiovascular health, reducing the risk of developing CVD and the risk of overall mortality.1 It is astonishing that 7–28% of patients with coronary heart disease still smoke, but around half of smokers are planning to quit.2,3 Because the habit is…
View more
Author(s):
Anne Mirjam Kerola
,
Silvia Rollefstad
,
Anne Grete Semb
Added:
2 years ago